Stay updated on MGL-3196 in NASH Patients: Clinical Trial

Sign up to get notified when there's something new on the MGL-3196 in NASH Patients: Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the MGL-3196 in NASH Patients: Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The record for the completed Phase 2 MGL-3196 NASH study is displayed, including its eligibility criteria, locations, study design, outcome measures, results dates, and study documents.
    Difference
    75%
    Check dated 2026-11-07T14:24:10.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    The site revision label changed from v3.7.2 to v3.8.0 while the page continued to show a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-31T15:26:16.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    A sitewide NIH notice announces a transition from using “Artificial Intelligence” to “Super Intelligence” terminology across NIH content.
    Difference
    1%
    Check dated 2026-10-24T17:35:48.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    The footer revision label changes from v3.7.1 to v3.7.2, while the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-17T17:12:10.000Z thumbnail image
  5. Check
    34 days ago
    Change Detected
    Summary
    The site footer revision changes from v3.7.0 to v3.7.1 while the page continues to display a 403 error.
    Difference
    0.2%
    Check dated 2026-10-10T17:59:51.000Z thumbnail image
  6. Check
    55 days ago
    Change Detected
    Summary
    The study page now shows a 403 Forbidden error, replacing the usual study details with an access-denied message.
    Difference
    21%
    Check dated 2026-09-19T20:58:50.000Z thumbnail image

Stay in the know with updates to MGL-3196 in NASH Patients: Clinical Trial

Enter your email address, and we'll notify you when there's something new on the MGL-3196 in NASH Patients: Clinical Trial page.